Prism Medical Announces New Appointment

Stuart Meldrum to Become CEO

TORONTO, Sept. 12, 2011 /CNW/ - Andrew A. McIntyre, the Chairman of the Board of Directors of Prism Medical Ltd. ("Prism Medical" or "the Company") (TSXV: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today announced the appointment of Stuart Meldrum as CEO effective immediately, September 12, 2011.

In his most recent position of CEO Prism Medical U.K., Stuart provided the leadership and operational skills required to substantially build the U.K. company.  This successful experience ideally positions him to build Prism Medical, adding value for customers, employees and shareholders.

He succeeds Andrew McIntyre who remains as Executive Chairman, focused on key long term strategic initiatives, and the provision of a smooth transition.

About Prism Medical Ltd.
Prism Medical Ltd. is one of the largest providers and manufacturers of durable medical equipment and related services to the mobility challenged in Canada, the U.S. and the U.K., with more than 100,000 installations and 200,000 product solutions sold.  The Prism Medical brands include Waverley Glen and ErgoSafe, North America's leading supplier of lifting, handling and repositioning aid products and services across Canada and the U.S.  Freeway and Prism Service & Repair are leading suppliers of moving and handling products and services in the U.K.  For further information visit

Forward-Looking Statements
This document contains forward-looking statements relating to our operations and to the environment in which we operate and our strategy, action plans and investments, which may involve estimates, forecasts and projections.  These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and/or are beyond our control.  A number of important factors could cause actual outcomes and results to differ materially from those expressed in these forward-looking statements.  These factors include those set forth in this report and our other public filings.  Consequently, readers should not place any undue reliance on such forward-looking statements.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

SOURCE Prism Medical Ltd.

For further information:

George Chiarucci     Catherine Love
Chief Financial Officer     TMX Equicom
416-260-2145 ext. 229     416-815-0700 ext. 266


Organization Profile

Prism Medical Ltd.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890